Panitumumab activity in metastatic colorectal cancer (mCRC) patients (pts) with low or negative tumor epidermal growth factor receptor (EGFr) levels: An updated analysis

被引：0
|
作者：
Mitchell, E. P.
Hecht, J. R.
Baranda, J.
Malik, I.
Richards, D.
Reiner, M.
Stout, S.
Amado, R. G.
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
[3] VA Med Ctr, Kansas City, MO USA
[4] Loma Linda Canc Ctr, Loma Linda, CA USA
[5] Tyler Canc Ctr, Tyler, TX USA
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4082
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Panitumumab antitumor activity in patients (pts) with metastatic colorectal cancer (mCRC) expressing ≥ 10% epidermal growth factor receptor (EGFr).
    Berlin, J.
    Neubauer, M.
    Swanson, P.
    Harker, W. G.
    Burris, H.
    Hecht, J. R.
    Navale, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 158S - 158S
  • [2] Panitumumab antitumor activity in patients (pts) with metastatic colorectal cancer (mCRC) expressing low (1-9%) or negative (<1%) levels of epidermal growth factor receptor (EGFr).
    Hecht, J.
    Mitchell, E.
    Baranda, J.
    Malik, I.
    Richards, D.
    Navale, L.
    D'Avirro, P.
    Amado, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 157S - 157S
  • [3] Panitumumab in metastatic colorectal cancer patients with low/negative epidermal growth factor receptor levels
    Mitchell, E.
    Hecht, J.
    Baranda, J.
    Malik, I
    Richards, D.
    Navale, L.
    D'Avirro, P.
    Amado, R.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 29 - 29
  • [4] Panitumumab activity in metastatic colorectal cancer patients with ≥10% epidermal growth factor receptor levels
    Chan, E.
    Neubauer, M.
    Swanson, P.
    Harker, W.
    Burris, H.
    Hecht, J.
    Navale, L.
    Brown, J.
    Amado, R.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 68 - 68
  • [5] Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
    Tubb, E. E.
    Nugent, M.
    Spielberger, J.
    Axelrod, R. A.
    Mitchell, E. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Association of gene copy number (GCN) of the epidermal growth factor receptor (EGFr) and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab monotherapy
    Berlin, J.
    Hecht, J. R.
    Reiner, M.
    Mullenix, M.
    Suggs, S.
    Radinsky, R.
    Freeman, D.
    Amado, R. G.
    Meropol, N. J.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 241 - 241
  • [7] Safety of panitumumab, a fully human monoclonal antibody against the epidermal growth factor receptor (EGFr), in patients (pts) with metastatic colorectal cancer (mCRC) across clinical trials
    Peeters, M.
    Van Cutsem, E.
    Berlin, J.
    Hecht, J. R.
    Ruiz, R.
    Navale, L.
    Amado, R.
    Meropol, N. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Randomized phase III study of panitumumab (pmab) with FOLFIRI versus FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis by tumor epidermal growth factor receptor (EGFR) staining
    Peeters, M.
    Cervantes-Ruiperez, A.
    Strickland, A.
    Ciuleanu, T.
    Mainwaring, P. N.
    Tzekova, V. I.
    Santoro, A.
    Johnson, C. W.
    Zhang, A.
    Gansert, J. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] IN VIVO IMMUNOLOGICAL EFFECTS OF ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) THERAPY IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS
    Chatzileontiadou, S.
    Rovati, B.
    Mariucci, S.
    Loupakis, F.
    Bencardino, K.
    Manzoni, M.
    Delfanti, S.
    Valentino, F.
    Ricci, V
    Brugnatelli, S.
    Ronzoni, M.
    Falcone, A.
    Danova, M.
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [10] Combining Anti-epidermal Growth Factor Receptor (EGFR) Therapy with Immunotherapy in Metastatic Colorectal Cancer (mCRC)
    Xiong, Feng
    Zhou, Yu-Wen
    Hao, Ya-Ting
    Wei, Gui-Xia
    Chen, Xiao-Rong
    Qiu, Meng
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 18 (4-5) : 185 - 192
12345